Stock Price Quote

FERMENTA BIOTECH LTD.

NSE : NABSE : 506414ISIN CODE : INE225B01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE278.75-10.9 (-3.76 %)
PREV CLOSE ( ) 289.65
OPEN PRICE ( ) 292.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 21030
TODAY'S LOW / HIGH ( )272.05 292.45
52 WK LOW / HIGH ( ) 145449
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1951
Management Info
Pradeep M Chandan - Chairman Prashant Nagre - Managing Director
Registered Office

Address A 1501, Thane One,Dil Complex, Ghodbhunder Road,Majiwada,
Thane,
Maharashtra-400610

Phone 022-66230800

Email info@fermentabiotech.com

Website www.fermentabiotech.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE

NEWS

17Apr Fermenta Biotech informs about disclos
Pursuant to Regulation 30 of the Securities and Exchange Board of India..
12Feb Fermenta Biotech informs about newspap
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosur..
31Dec Fermenta Biotech informs about closure
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regu..
21Aug Fermenta Biotech informs about loss of
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure..
24Jul Fermenta Biotech informs about change
Fermenta Biotech has informed that Srikant N. Sharma, Company Secretary..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit349.98-187.44
Gross Profit 424.45 -46.0800000000004
Operating Profit 523.58451.4
Net Sales 1462.523070.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

TTK Healthcare (BSE)
peergroup  1233.80 (0.44%)
M.Cap ( in Cr)1743.40
Jagsonpal Pharma (BSE)
peergroup  243.55 (1.82%)
M.Cap ( in Cr)1618.11
Alivus Life Sciences (BSE)
peergroup  1034.35 (0.39%)
M.Cap ( in Cr)12674.62
Oxygenta Pharma (BSE)
peergroup  85.05 (4.70%)
M.Cap ( in Cr)314.54
Bafna Pharma (BSE)
peergroup  79.74 (4.99%)
M.Cap ( in Cr)188.64

Shareholding Pattern

PROMOTERS 64.09%
NON-INSTITUTION 35.89%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Fermenta Biotech Ltd.

Fermenta Biotech Ltd. was incorporated in the year 1951. Its today's share price is 278.75. Its current market capitalisation stands at Rs 820.39 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3070.9 Cr and Total Income of Rs.3152.45 Cr. The company's management includes Ramanand Mundkur, Rajeshwari Datla, Varadvinayak Vijay Khambete, Prashant Nagre, Anupama Datla Desai, Satish Varma, Krishna Datla, Pramod Kasat, Rajashri Ojha, Pradeep M Chandan.

It is listed on the BSE with a BSE Code of 506414 , NSE with an NSE Symbol of and ISIN of INE225B01021. It's Registered office is at A 1501, Thane One,Dil Complex, Ghodbhunder Road,MajiwadaThane-400610, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Deloitte Haskins & Sells LLP, SR Batliboi & Associates LLP, SRBC & Co LLP

1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.
1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.
Close X
OPEN

DEMAT ACCOUNT

AND START YOUR

INVESTMENT

JOURNEY WITH US
(You will receive a Call & SMS from our end)
Popup-Character

Disclaimer: NIRMAL BANG SECURITIES PVT LTD: Investment in Securities market are subject to market risks. Read all the related documents carefully before investing. Please read the Do’s and Don’ts prescribed by the Commodity Exchange before trading. We do not offer PMS Service for the Commodity segment. Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO. The securities quoted are exemplary and are not recommendatory. BSE (Member ID- 498): INB011072759, INF011072759, Exchange Registered Member in CDS; NSE MEMEBR ID- 09391): INB230939139, INF230939139, INE230939139; MSEI Member ID-1067): INB260939138, INF260939138, INE260939139: Single Registration No. INZ000202536, PMS Registration No: INP000002981; Research Analyst Registration No: INH000001766; NSDL/ CDSL: IN-DP-CDSL 37-99; Exchange Member ID: MCX - 56460, NCDEX - 1268, ICEX – 2073. Regd. Office: B-2, 301/302, 3rd Floor, Marathon Innova, Off Ganpatrao Kadam Marg, Lower Parel (W), Mumbai - 400013. Tel: 62738000/01; Fax: 62738010 | *NIRMAL BANG NIVESHALAYA PVT LTD: ARN – 111233, Mutual Fund Distributor. Mutual Fund Investments are subject to market risks. Please read the offer documents carefully before Investing.” Regd. Office: B - 201, Khandelwal House, Poddar Road, Near Poddar Park, Malad (East). Mumbai – 400097. | **NIRMAL BANG INSURANCE BROKING PVT LTD: IRDAI Registration No: 795 and Registration Code For the Insurance Broker: IRDAI/DB889/2021. Insurance is the subject matter of the solicitation. For more details on policy terms, conditions, exclusions, limitations, please refer/read policy brochure carefully before concluding sale.